Introduction
John Carreyrou’s investigation into Theranos remains one of the most studied pieces of business journalism of the last decade. His reporting for The Wall Street Journal — and his subsequent book, Bad Blood — earned him the George Polk Award for Financial Reporting, the Gerald Loeb Award for Distinguished Business and Financial Journalism, and the Barlett & Steele Silver Award for Investigative Business Journalism. (Carreyrou is separately a two-time Pulitzer Prize winner for other reporting — a Medicare fraud investigation and an earlier corporate-scandals series — recognition that speaks to the caliber of investigator who took on Theranos.)
I was one of the physicians he spoke with in the course of that reporting, describing a patient’s Theranos lab results that didn’t match her clinical presentation. What struck me at the time — and what still shapes how I approach every medical chart I review for attorneys — was how much of Carreyrou’s reporting power came from something almost unglamorous: methodically comparing what a company said against what the underlying data actually showed.
The Investigative Method Behind the Exposé
Compare the Claim to the Record
Theranos’s public claims were dramatic — a “revolutionary” technology that could run hundreds of tests from a finger-prick of blood. Carreyrou’s reporting didn’t dismantle that claim with a counter-narrative. It dismantled it by comparing the claim to what the lab data, former employees, and patients actually experienced. The gap between the story and the record was the story.
Talk to the People Closest to the Data
Some of the most important sourcing in the Theranos investigation came from people with direct, firsthand access to results and outcomes — lab employees, and physicians like myself who saw what happened when a patient’s Theranos result didn’t match reality. Secondhand accounts and press releases weren’t what broke the story open; primary documentation and firsthand clinical observation were.
Let the Chronology Do the Work
Much of the eventual regulatory and legal case against Theranos depended on establishing a clear timeline: what the company knew, and when. That same principle — a precise, well-documented chronology — is often the single most persuasive tool in a malpractice case.
Applying Investigative Discipline to a Malpractice File
Don’t Start with a Theory — Start with the Record
It’s tempting to build a case around the theory of what went wrong and then look for supporting evidence. The more durable approach — the one investigative journalism and forensic chart review share — is to read the entire record first, without a predetermined conclusion, and let the documented facts show where the standard of care actually broke down.
Build a Clean, Defensible Timeline
A forensic chart review reconstructs the same kind of chronology investigative reporters rely on: every entry, every order, every result, placed in sequence, so gaps and contradictions become visible instead of buried across hundreds of pages.
Prioritize Primary Documentation
Just as Carreyrou’s reporting leaned on primary sources rather than secondhand claims, the strongest malpractice exhibits come from the primary chart — lab values, vital signs, medication administration records, and EHR audit trails — rather than summaries or secondhand characterizations of what happened.
Why This Is a Non-Testifying Role, Not a Testifying One
Carreyrou’s job was to report the story publicly, with his name on it. Mine, in litigation, is different by design. A non-testifying medical consultant does the same kind of rigorous, primary-source analysis — but the resulting narrative and argument belong to the attorney, not the consultant. That structure keeps the clinical analysis focused on accuracy rather than performance, while giving the attorney everything needed to tell the story persuasively in deposition or trial.
Frequently Asked Questions
What awards did John Carreyrou win for his Theranos reporting specifically? His Theranos coverage earned the George Polk Award for Financial Reporting, the Gerald Loeb Award for Distinguished Business and Financial Journalism, and the Barlett & Steele Silver Award for Investigative Business Journalism. His two Pulitzer Prizes were awarded for separate reporting — a Medicare fraud investigation and an earlier series on corporate scandals.
What can a malpractice attorney learn from investigative journalism methods? The core discipline — comparing claims to underlying data, prioritizing primary sources, and building a precise chronology — translates directly into building a persuasive, well-documented malpractice case.
Why does a documented chronology matter so much in a malpractice case? Juries and judges respond to a clear “what happened, and when” narrative. A precise timeline, built directly from the chart, is often more persuasive than expert opinion alone.
How is a non-testifying consultant’s role different from a reporter’s or a testifying expert’s? All three build a fact-based narrative from primary records, but a non-testifying consultant’s analysis stays behind the scenes — supporting the attorney’s advocacy rather than becoming a public-facing account or courtroom testimony itself.
Conclusion
The Theranos exposé wasn’t won with a dramatic accusation — it was won by methodically comparing claims to records and letting the documentation speak. That’s the same discipline behind every flat-rate chart review at Exhibit A Medical Detective: read the record first, build the timeline, and hand the attorney a story the chart itself already proves.
Disclaimer
This article is for general informational purposes only and does not constitute legal advice. Details of John Carreyrou’s reporting and awards are drawn from publicly available biographical sources and publisher materials; his Pulitzer Prizes were awarded for reporting unrelated to Theranos, while his Theranos-specific coverage earned separate industry awards, as noted above.